2nd Quarter - Report
LMH STRATEGIC SOLUTIONS for ALKERMES, INC.
Client
Income
$60,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Medicare/Medicaid issues. Medicaid drug rebate program. Prescription drug pricing, including MDRP Substance Use Disorder Policy. Implementation of Inflation Reduction Act of 2022. H.R.946 - ORPHAN Cures Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALANNA TEMME | Legislative Director, U.S. Representative Jon Porter |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.